VKTX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 4.10%

Insider Buying (Last 12 Months): $29,946.00

Insider Selling (Last 12 Months): $58,693,737.83

Viking Therapeutics Insider Trading History Chart

Viking Therapeutics Share Price & Price History

^$31.11

▼ -0.18 (-0.58%)

As of 07/11/2025 05:00 PM ET

Days: 30 | 90 | 365

Viking Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
7/3/2025	Brian Lian	CEO	Sell	26,889	$27.80	$747,514.20	2,388,014
7/3/2025	Greg Zante	CFO	Sell	4,266	$27.76	$118,424.16	168,660
7/3/2025	Marianna Mancini	COO	Sell	4,266	$27.77	$118,466.82	377,535
3/31/2025	Sarah Kathryn Rouan	Director	Buy	1,240	$24.15	$29,946.00	1,240
1/6/2025	Brian Lian	CEO	Sell	194,490	$42.75	$8,314,447.50	2,366,570
1/6/2025	Greg Zante	CFO	Sell	50,309	$42.75	$2,150,709.75	165,259
1/6/2025	Marianna Mancini	COO	Sell	54,215	$42.75	$2,317,691.25	374,134
11/8/2024	Lawson Macartney	Director	Sell	2,000	$68.67	$137,340.00	47,965
10/28/2024	Greg Zante	CFO	Sell	131,687	$76.61	$10,088,541.07	149,366
10/25/2024	Sarah Kathryn Rouan	Director	Sell	11,000	$80.89	$889,790.00	9,500
9/20/2024	Brian Lian	CEO	Sell	216,130	$70.83	$15,308,487.90	2,304,927
9/20/2024	J. Matthew Singleton	Director	Sell	10,300	$69.50	$715,850.00	9,500
8/21/2024	Brian Lian	CEO	Sell	1,000	$69.90	$69,900.00	2,354,927
8/21/2024	J. Matthew Singleton	Director	Sell	5,700	$69.72	$397,404.00	9,500
8/19/2024	Brian Lian	CEO	Sell	112,870	$65.80	$7,426,846.00	2,354,927
8/19/2024	J. Matthew Singleton	Director	Sell	16,000	$62.22	$995,520.00	9,500
8/14/2024	J. Matthew Singleton	Director	Sell	20,786	$57.53	$1,195,818.58	9,500
7/30/2024	Brian Lian	CEO	Sell	115,859	$57.58	$6,671,161.22	2,354,927
7/30/2024	Marianna Mancini	COO	Sell	18,026	$57.13	$1,029,825.38	362,149
5/3/2024	Greg Zante	CFO	Sell	66,756	$74.69	$4,986,005.64	174,854
5/1/2024	Marianna Mancini	COO	Sell	281,425	$78.66	$22,136,890.50	348,508
2/8/2024	Brian Lian	CEO	Sell	269,079	$26.87	$7,230,152.73	2,184,882
2/8/2024	Sarah Kathryn Rouan	Director	Sell	25,000	$28.05	$701,250.00
1/30/2024	Brian Lian	CEO	Sell	35,000	$23.95	$838,250.00	2,264,882
1/19/2024	Sarah Kathryn Rouan	Director	Sell	30,000	$23.05	$691,500.00
1/4/2024	Greg Zante	CFO	Sell	15,000	$17.90	$268,500.00	180,730
5/16/2023	Charles A. Rowland, Jr.	Director	Sell	40,000	$25.00	$1,000,000.00	30,000
5/1/2023	Brian Lian	CEO	Sell	45,000	$22.45	$1,010,250.00	2,197,963
4/24/2023	Lawson Macartney	Director	Sell	16,000	$22.00	$352,000.00	47,965
4/19/2023	Brian Lian	CEO	Sell	35,000	$21.45	$750,750.00	2,242,963
4/17/2023	Brian Lian	CEO	Sell	155,000	$20.45	$3,169,750.00	2,277,963
4/17/2023	Greg Zante	CFO	Sell	7,500	$20.00	$150,000.00	149,279
4/17/2023	Lawson Macartney	Director	Sell	20,786	$20.00	$415,720.00	47,965
4/17/2023	Marianna Mancini	COO	Sell	12,500	$20.00	$250,000.00	287,763
4/13/2023	Brian Lian	CEO	Sell	79,336	$18.45	$1,463,749.20	2,307,963
4/11/2023	Greg Zante	CFO	Sell	56,295	$18.00	$1,013,310.00	149,279
4/3/2023	Brian Lian	CEO	Sell	22,000	$17.85	$392,700.00	2,232,963
4/3/2023	Greg Zante	CFO	Sell	30,911	$18.00	$556,398.00	147,778
3/31/2023	Brian Lian	CEO	Sell	67,970	$17.45	$1,186,076.50	2,254,963
3/30/2023	Greg Zante	CFO	Sell	131,029	$17.00	$2,227,493.00	147,778
3/29/2023	Marianna Mancini	COO	Sell	41,242	$16.00	$659,872.00	261,895

See Full Table

SEC Filings (Institutional Ownership Changes) for Viking Therapeutics (NASDAQ:VKTX)

76.03% of Viking Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Viking Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
7/11/2025	Profit Investment Management LLC	116,852	$3.10M	2.8%	-0.8%	0.104%
7/11/2025	Farther Finance Advisors LLC	2,041	$54K	0.0%	+571.4%	0.002%
7/11/2025	Kingstone Capital Partners Texas LLC	51,576	$1.37M	0.0%	N/A	0.046%
7/10/2025	Exchange Traded Concepts LLC	53,514	$1.42M	0.0%	+61.1%	0.048%
7/10/2025	Wealth Enhancement Advisory Services LLC	8,993	$0.25M	0.0%	N/A	0.008%
7/9/2025	Pallas Capital Advisors LLC	22,275	$0.59M	0.0%	+5.3%	0.020%
7/9/2025	Harbor Capital Advisors Inc.	103,546	$2.74M	0.1%	-10.1%	0.092%
7/8/2025	Parallel Advisors LLC	1,818	$48K	0.0%	+33.4%	0.002%
7/7/2025	Wesbanco Bank Inc.	52,000	$1.38M	0.0%	+118.5%	0.046%
6/18/2025	Voya Investment Management LLC	366,379	$8.85M	0.0%	-6.1%	0.326%
6/3/2025	Inspire Investing LLC	14,255	$0.34M	0.0%	+41.3%	0.013%
5/29/2025	Rhumbline Advisers	129,195	$3.12M	0.0%	-0.8%	0.115%
5/28/2025	Strs Ohio	25,000	$0.60M	0.0%	N/A	0.022%
5/28/2025	Wealth Management Associates Inc.	9,975	$0.24M	0.1%	N/A	0.009%
5/20/2025	Flaharty Asset Management LLC	2,299	$56K	0.0%	N/A	0.002%
5/19/2025	UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC	470,028	$11.35M	0.0%	+1.4%	0.419%
5/16/2025	Woodline Partners LP	301,078	$7.27M	0.0%	+222.7%	0.268%
5/16/2025	MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	8,556	$0.22M	0.0%	-20.8%	0.008%
5/16/2025	Integrated Wealth Concepts LLC	9,533	$0.23M	0.0%	N/A	0.008%
5/16/2025	Granahan Investment Management LLC	367,961	$8.89M	0.4%	+20.4%	0.328%
5/16/2025	EFG Asset Management North America Corp.	49,124	$1.19M	0.2%	-31.6%	0.044%
5/16/2025	Eventide Asset Management LLC	255,407	$6.17M	0.1%	-42.3%	0.227%
5/16/2025	Cinctive Capital Management LP	48,919	$1.18M	0.1%	+644.0%	0.044%
5/16/2025	Curi RMB Capital LLC	35,599	$0.86M	0.0%	+490.0%	0.032%
5/16/2025	Alliancebernstein L.P.	1,039,417	$25.10M	0.0%	-6.8%	0.925%
5/16/2025	AQR Capital Management LLC	145,119	$3.44M	0.0%	-73.0%	0.129%
5/16/2025	683 Capital Management LLC	305,000	$7.37M	0.5%	+8.9%	0.272%
5/16/2025	ADAR1 Capital Management LLC	59,413	$1.44M	0.3%	+538.8%	0.053%
5/15/2025	Braidwell LP	1,435,955	$34.68M	1.2%	-3.0%	1.279%
5/15/2025	Royal Bank of Canada	347,716	$8.40M	0.0%	+13.0%	0.310%
5/15/2025	Apis Capital Advisors LLC	112,000	$2.71M	1.3%	+16.7%	0.100%
5/15/2025	Quarry LP	1,205	$29K	0.0%	+1,621.4%	0.001%
5/15/2025	Second Line Capital LLC	50,381	$1.22M	0.3%	+1.8%	0.045%
5/15/2025	Activest Wealth Management	1,608	$39K	0.0%	-25.7%	0.001%
5/15/2025	Magnetar Financial LLC	9,687	$0.23M	0.0%	-79.9%	0.009%
5/15/2025	Tema Etfs LLC	19,231	$0.46M	0.1%	-4.9%	0.017%
5/15/2025	Landscape Capital Management L.L.C.	10,003	$0.24M	0.0%	N/A	0.009%
5/14/2025	Affinity Asset Advisors LLC	25,000	$0.60M	0.1%	N/A	0.022%
5/14/2025	Rafferty Asset Management LLC	183,769	$4.44M	0.0%	-32.2%	0.164%
5/14/2025	FORA Capital LLC	11,115	$0.27M	0.0%	-59.9%	0.010%
5/14/2025	Comerica Bank	39,294	$0.95M	0.0%	-34.6%	0.035%
5/14/2025	AlphaQuest LLC	11,753	$0.28M	0.0%	+506.4%	0.010%
5/14/2025	Hsbc Holdings PLC	17,875	$0.43M	0.0%	+205.6%	0.016%
5/13/2025	Aptus Capital Advisors LLC	50,381	$1.22M	0.0%	+3.4%	0.045%
5/13/2025	Northern Trust Corp	538,636	$13.01M	0.0%	+0.5%	0.480%
5/13/2025	Steward Partners Investment Advisory LLC	238,035	$5.75M	0.1%	+6.1%	0.212%
5/13/2025	Raymond James Financial Inc.	647,391	$15.63M	0.0%	+4.7%	0.576%
5/13/2025	American Century Companies Inc.	297,729	$7.19M	0.0%	-1.3%	0.265%
5/13/2025	Tejara Capital Ltd	37,910	$0.92M	0.4%	N/A	0.034%
5/13/2025	Fox Run Management L.L.C.	33,431	$0.81M	0.1%	N/A	0.030%
5/13/2025	Oak Ridge Investments LLC	12,950	$0.31M	0.0%	+17.5%	0.012%
5/13/2025	E Fund Management Co. Ltd.	17,174	$0.42M	0.0%	-10.9%	0.015%
5/13/2025	Russell Investments Group Ltd.	98,034	$2.37M	0.0%	-62.6%	0.087%
5/12/2025	Nuveen LLC	384,379	$9.28M	0.0%	N/A	0.342%
5/12/2025	Aigen Investment Management LP	13,780	$0.33M	0.1%	N/A	0.012%
5/12/2025	Virtu Financial LLC	14,350	$0.35M	0.0%	-66.3%	0.013%
5/12/2025	Invesco Ltd.	84,981	$2.05M	0.0%	-90.3%	0.076%
5/12/2025	Connor Clark & Lunn Investment Management Ltd.	597,515	$14.43M	0.1%	+59.2%	0.532%
5/12/2025	Swiss National Bank	194,300	$4.69M	0.0%	-1.0%	0.173%
5/9/2025	Deutsche Bank AG	6,911	$0.17M	0.0%	+7.5%	0.006%
5/9/2025	Charles Schwab Investment Management Inc.	711,897	$17.19M	0.0%	-2.3%	0.634%
5/9/2025	Vanguard Group Inc.	10,164,257	$245.47M	0.0%	-0.1%	9.050%
5/9/2025	New Age Alpha Advisors LLC	50,000	$1.21M	0.1%	N/A	0.045%
5/9/2025	Raiffeisen Bank International AG	25,000	$0.64M	0.0%	+108.3%	0.022%
5/9/2025	Blair William & Co. IL	308,565	$7.45M	0.0%	+13.5%	0.275%
5/9/2025	NJ State Employees Deferred Compensation Plan	48,000	$1.16M	0.1%	+26.3%	0.043%
5/9/2025	PNC Financial Services Group Inc.	3,857	$93K	0.0%	+38.8%	0.003%
5/8/2025	US Bancorp DE	4,793	$0.12M	0.0%	+25.4%	0.004%
5/8/2025	Harbour Investments Inc.	14,635	$0.35M	0.0%	+146,250.0%	0.013%
5/8/2025	Banque Cantonale Vaudoise	3,216	$77K	0.0%	N/A	0.003%
5/7/2025	Fiera Capital Corp	275,962	$6.66M	0.0%	+2.4%	0.246%
5/7/2025	TCW Group Inc.	75,054	$1.81M	0.0%	+21.7%	0.067%
5/7/2025	LPL Financial LLC	118,613	$2.87M	0.0%	+22.7%	0.106%
5/7/2025	Zurcher Kantonalbank Zurich Cantonalbank	30,446	$0.74M	0.0%	+13.5%	0.027%
5/7/2025	Mediolanum International Funds Ltd	25,258	$0.65M	0.0%	N/A	0.022%
5/7/2025	Knights of Columbus Asset Advisors LLC	18,729	$0.45M	0.0%	+2.7%	0.017%
5/6/2025	Assetmark Inc.	12,915	$0.31M	0.0%	+6.5%	0.011%
5/6/2025	Cetera Investment Advisers	144,349	$3.49M	0.0%	+67.5%	0.129%
5/6/2025	1492 Capital Management LLC	41,058	$0.99M	0.5%	N/A	0.037%
5/6/2025	Bank Julius Baer & Co. Ltd Zurich	7,078	$0.17M	0.0%	+42.1%	0.006%
5/6/2025	Universal Beteiligungs und Servicegesellschaft mbH	8,519	$0.21M	0.0%	N/A	0.008%
5/6/2025	Y Intercept Hong Kong Ltd	27,911	$0.67M	0.0%	N/A	0.025%
5/5/2025	Lewis Asset Management LLC	43,675	$1.06M	0.9%	+5.8%	0.039%
5/5/2025	Allianz Asset Management GmbH	96,363	$2.33M	0.0%	-27.2%	0.086%
5/5/2025	Montag A & Associates Inc.	5,862	$0.14M	0.0%	-46.2%	0.005%
5/5/2025	Kestra Private Wealth Services LLC	8,828	$0.21M	0.0%	+15.4%	0.008%
5/5/2025	Formidable Asset Management LLC	40,768	$0.99M	0.2%	+32.1%	0.036%
5/2/2025	Kintayl Capital LP	99,973	$2.41M	1.7%	+96.0%	0.089%
5/2/2025	Victory Capital Management Inc.	13,140	$0.32M	0.0%	-40.3%	0.012%
5/2/2025	Wealthfront Advisers LLC	8,759	$0.21M	0.0%	+76.1%	0.008%
5/2/2025	Signaturefd LLC	2,830	$68K	0.0%	+126.8%	0.003%
5/1/2025	CWM LLC	3,542	$86K	0.0%	+36.1%	0.003%
5/1/2025	Caas Capital Management LP	43,207	$1.04M	0.1%	+151.1%	0.038%
5/1/2025	Xponance Inc.	14,470	$0.35M	0.0%	+3.2%	0.013%
4/30/2025	Significant Wealth Partners LLC	8,993	$0.22M	0.1%	+66.6%	0.008%
4/30/2025	Banque Pictet & Cie SA	9,855	$0.24M	0.0%	N/A	0.009%
4/29/2025	U.S. Capital Wealth Advisors LLC	35,751	$0.86M	0.0%	-19.1%	0.032%
4/29/2025	Financial Counselors Inc.	55,476	$1.34M	0.0%	+43.5%	0.049%
4/29/2025	Envestnet Asset Management Inc.	48,139	$1.16M	0.0%	+15.0%	0.043%
4/29/2025	Concurrent Investment Advisors LLC	9,102	$0.22M	0.0%	N/A	0.008%

Data available starting January 2016

See Full Table

Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trials to treat patients with biopsy-confirmed non-alcoholic steatohepatitis, as well as NAFLD. It also develops VK5211, an orally available non-steroidal selective androgen receptor modulator that is in Phase II clinical trials for the treatment of patients recovering from non-elective hip fracture surgery; VK0612, an orally available Phase IIb-ready drug candidate for type 2 diabetes; VK2735, a novel dual agonist of the glucagon-like peptide, which is in Phase 1 SAD/MAD clinical trial, and VK0214, an orally available tissue and receptor-subtype selective agonist of the TRß for X-linked adrenoleukodystrophy. The company was incorporated in 2012 and is headquartered in San Diego, California.

Today's Range

Now: $31.11

$30.17

$31.23

50 Day Range

MA: $27.61

$24.86

$31.29

52 Week Range

Now: $31.11

$18.92

$81.73

Volume

2,829,639 shs

Average Volume

4,066,393 shs

Market Capitalization

$3.49 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.62

Who are the company insiders with the largest holdings of Viking Therapeutics?: Viking Therapeutics' top insider shareholders include:
Brian Lian (CEO)
Marianna Mancini (COO)
Greg Zante (CFO)
Lawson Macartney (Director)
J Matthew Singleton (Director)
Sarah Kathryn Rouan (Director)
Learn More about top insider investors at Viking Therapeutics.
Who are the major institutional investors of Viking Therapeutics?: Viking Therapeutics' top institutional investors include:
Profit Investment Management LLC — 0.10%
Harbor Capital Advisors Inc. — 0.09%
Exchange Traded Concepts LLC — 0.05%
Wesbanco Bank Inc. — 0.05%
Kingstone Capital Partners Texas LLC — 0.05%
Pallas Capital Advisors LLC — 0.02%
Learn More about top institutional investors of Viking Therapeutics stock.
Which major investors are selling Viking Therapeutics stock?: In the previous quarter, VKTX stock was sold by these institutional investors:
Harbor Capital Advisors Inc.
Profit Investment Management LLC
Within the last year, company insiders that have sold Viking Therapeutics company stock include:
Brian Lian (CEO)
Marianna Mancini (COO)
Greg Zante (CFO)
Lawson Macartney (Director)
J Matthew Singleton (Director)
Sarah Kathryn Rouan (Director)
Learn More investors selling Viking Therapeutics stock.
Which major investors are buying Viking Therapeutics stock?: Within the previous quarter, VKTX stock was purchased by institutional investors including:
Kingstone Capital Partners Texas LLC
Wesbanco Bank Inc.
Exchange Traded Concepts LLC
Wealth Enhancement Advisory Services LLC
Farther Finance Advisors LLC
Pallas Capital Advisors LLC
Parallel Advisors LLC